Anika Therapeutics, Inc. Income Tax Expense
Anika Therapeutics, Inc. (ANIK) reported Income Tax Expense of $71.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-07-29
- Anika Therapeutics, Inc. income tax expense (benefit) for the quarter ending 2026-06-30 was $71.00K, a 89.57% decline year-over-year.
- Anika Therapeutics, Inc. income tax expense (benefit) for the quarter ending 2026-03-31 was $235.00K, a 164.04% increase year-over-year.
- Anika Therapeutics, Inc. income tax expense (benefit) for the quarter ending 2025-12-31 was -$1.04M, a 141.07% decline year-over-year.
- Anika Therapeutics, Inc. income tax expense (benefit) for the quarter ending 2025-09-30 was $939.00K, a 56.73% decline year-over-year.
- Anika Therapeutics, Inc. income tax expense (benefit) for fiscal 2025 was $672.00K, a 88.92% decline from fiscal 2024.
- Anika Therapeutics, Inc. income tax expense (benefit) for fiscal 2024 was $6.06M, a 8.05% decline from fiscal 2023.
- Anika Therapeutics, Inc. income tax expense (benefit) for fiscal 2023 was $6.59M, a 210.50% increase from fiscal 2022.
- Anika Therapeutics, Inc. income tax expense (benefit) for fiscal 2022 was $2.12M.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 3 month as first filed | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 6 month as first filed | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 9 month as first filed | Income Tax Expense (Benefit) 12 month | Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $71.00K 10-Q · filed 2026-07-29 | $306.00K 10-Q · filed 2026-07-29 | -$731.00K derived: sum of 3 quarters · filed 2026-07-29 | $208.00K derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2026-03-31 | $235.00K 10-Q · filed 2026-04-30 | -$802.00K derived: sum of 2 quarters · filed 2026-04-30 | $137.00K derived: sum of 3 quarters · filed 2026-04-30 | $818.00K derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-12-31 | -$1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$98.00K derived: sum of 2 quarters · filed 2026-03-03 | $583.00K derived: sum of 3 quarters · filed 2026-07-29 | $672.00K 10-K · filed 2026-03-03 | ||||
| 2025-09-30 | $939.00K 10-Q · filed 2025-11-05 | $1.62M derived: sum of 2 quarters · filed 2026-07-29 | $1.71M 10-Q · filed 2025-11-05 | $4.23M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-06-30 | $681.00K 10-Q · filed 2026-07-29 | $770.00K 10-Q · filed 2026-07-29 | $3.29M derived: sum of 3 quarters · filed 2026-07-29 | $5.46M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-03-31 | $89.00K 10-Q · filed 2026-04-30 | $2.61M derived: sum of 2 quarters · filed 2026-04-30 | $4.78M derived: sum of 3 quarters · filed 2026-04-30 | $6.11M derived: sum of 4 quarters · filed 2026-04-30 | ||||
| 2024-12-31 | $2.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $4.70M derived: sum of 2 quarters · filed 2026-03-03 | $6.02M derived: sum of 3 quarters · filed 2026-03-03 | $6.06M 10-K · filed 2026-03-03 | ||||
| 2024-09-30 | $2.17M 10-Q · filed 2025-11-05 | $2.31M 10-Q · filed 2024-11-04 | $3.50M derived: sum of 2 quarters · filed 2025-11-05 | $3.54M 10-Q · filed 2025-11-05 | $3.19M 10-Q · filed 2024-11-04 | $12.59M derived: sum of 4 quarters · filed 2026-03-03 | ||
| 2024-06-30 | $1.33M 10-Q · filed 2025-07-30 | $844.00K 10-Q · filed 2024-08-08 | $1.37M 10-Q · filed 2025-07-30 | $887.00K 10-Q · filed 2024-08-08 | $10.42M derived: sum of 3 quarters · filed 2026-03-03 | $9.96M derived: sum of 4 quarters · filed 2026-03-03 | ||
| 2024-03-31 | $43.00K 10-Q · filed 2025-05-09 | $9.09M derived: sum of 2 quarters · filed 2026-03-03 | $8.63M derived: sum of 3 quarters · filed 2026-03-03 | $8.30M derived: sum of 4 quarters · filed 2026-03-03 | ||||
| 2023-12-31 | $9.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $8.59M derived: sum of 2 quarters · filed 2026-03-03 | $8.26M derived: sum of 3 quarters · filed 2026-03-03 | $6.59M 10-K · filed 2026-03-03 | -$2.66M 10-K · filed 2024-03-15 | |||
| 2023-09-30 | -$463.00K 10-Q · filed 2024-11-04 | -$792.00K derived: sum of 2 quarters · filed 2024-11-04 | -$2.46M 10-Q · filed 2024-11-04 | $2.07M derived: sum of 4 quarters · filed 2025-03-17 | ||||
| 2023-06-30 | -$329.00K 10-Q · filed 2024-08-08 | -$1.99M 10-Q · filed 2024-08-08 | $2.54M derived: sum of 3 quarters · filed 2025-03-17 | $1.35M derived: sum of 4 quarters · filed 2025-03-17 | ||||
| 2023-03-31 | -$1.66M 10-Q · filed 2024-05-08 | $2.86M derived: sum of 2 quarters · filed 2025-03-17 | $1.68M derived: sum of 3 quarters · filed 2025-03-17 | $1.24M derived: sum of 4 quarters · filed 2025-03-17 | ||||
| 2022-12-31 | $4.53M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $3.34M derived: sum of 2 quarters · filed 2025-03-17 | $2.90M derived: sum of 3 quarters · filed 2025-03-17 | $2.12M 10-K · filed 2025-03-17 | -$3.89M 10-K · filed 2023-03-16 | |||
| 2022-09-30 | -$1.19M 10-Q · filed 2023-11-03 | -$1.63M derived: sum of 2 quarters · filed 2023-11-03 | -$2.40M 10-Q · filed 2023-11-03 | -$5.78M derived: sum of 4 quarters · filed 2024-03-15 | ||||
| 2022-06-30 | -$442.00K 10-Q · filed 2023-08-08 | -$1.22M 10-Q · filed 2023-08-08 | -$4.59M derived: sum of 3 quarters · filed 2024-03-15 | -$3.90M derived: sum of 4 quarters · filed 2024-03-15 | ||||
| 2022-03-31 | -$775.00K 10-Q · filed 2023-05-09 | -$4.15M derived: sum of 2 quarters · filed 2024-03-15 | -$3.46M derived: sum of 3 quarters · filed 2024-03-15 | -$859.00K derived: sum of 4 quarters · filed 2024-03-15 | ||||
| 2021-12-31 | -$3.38M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | -$2.68M derived: sum of 2 quarters · filed 2024-03-15 | -$84.00K derived: sum of 3 quarters · filed 2024-03-15 | -$1.71M 10-K · filed 2024-03-15 | ||||
| 2021-09-30 | $694.00K 10-Q · filed 2022-11-09 | $3.29M derived: sum of 2 quarters · filed 2022-11-09 | $1.67M 10-Q · filed 2022-11-09 | -$811.00K derived: sum of 4 quarters · filed 2023-03-16 | ||||
| 2021-06-30 | $2.60M 10-Q · filed 2022-08-04 | $976.00K 10-Q · filed 2022-08-04 | -$1.50M derived: sum of 3 quarters · filed 2023-03-16 | -$3.25M derived: sum of 4 quarters · filed 2023-03-16 | ||||
| 2021-03-31 | -$1.62M 10-Q · filed 2022-05-06 | -$4.10M derived: sum of 2 quarters · filed 2023-03-16 | -$5.85M derived: sum of 3 quarters · filed 2023-03-16 | -$7.84M derived: sum of 4 quarters · filed 2023-03-16 | ||||
| 2020-12-31 | -$2.48M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$4.22M derived: sum of 2 quarters · filed 2023-03-16 | -$6.22M derived: sum of 3 quarters · filed 2023-03-16 | -$4.64M 10-K · filed 2023-03-16 | ||||
| 2020-09-30 | -$1.74M 10-Q · filed 2021-11-05 | -$3.74M derived: sum of 2 quarters · filed 2021-11-05 | -$2.16M 10-Q · filed 2021-11-05 | -$1.05M derived: sum of 4 quarters · filed 2022-03-11 | ||||
| 2020-06-30 | -$2.00M 10-Q · filed 2021-08-06 | -$417.00K 10-Q · filed 2021-08-06 | $694.00K derived: sum of 3 quarters · filed 2022-03-11 | $4.03M derived: sum of 4 quarters · filed 2022-03-11 | ||||
| 2020-03-31 | $1.58M 10-Q · filed 2021-05-07 | $2.69M derived: sum of 2 quarters · filed 2022-03-11 | $6.02M derived: sum of 3 quarters · filed 2022-03-11 | $9.04M derived: sum of 4 quarters · filed 2022-03-11 | ||||
| 2019-12-31 | $1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $4.44M derived: sum of 2 quarters · filed 2022-03-11 | $7.46M derived: sum of 3 quarters · filed 2022-03-11 | $8.93M 10-K · filed 2022-03-11 | ||||
| 2019-09-30 | $3.33M 10-Q · filed 2020-11-05 | $6.34M derived: sum of 2 quarters · filed 2020-11-05 | $7.82M 10-Q · filed 2020-11-05 | $10.41M derived: sum of 4 quarters · filed 2021-04-26 | ||||
| 2019-06-30 | $3.01M 10-Q · filed 2020-08-07 | $4.49M 10-Q · filed 2020-08-07 | $7.08M derived: sum of 3 quarters · filed 2021-04-26 | $8.58M derived: sum of 4 quarters · filed 2021-04-26 | ||||
| 2019-03-31 | $1.47M 10-Q · filed 2020-05-22 | $4.07M derived: sum of 2 quarters · filed 2021-04-26 | $5.56M derived: sum of 3 quarters · filed 2021-04-26 | $7.01M derived: sum of 4 quarters · filed 2021-04-26 | ||||
| 2018-12-31 | $2.60M derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-26 | $4.09M derived: sum of 2 quarters · filed 2021-04-26 | $5.54M derived: sum of 3 quarters · filed 2021-04-26 | $4.49M 10-K/A · filed 2021-04-26 | ||||
| 2018-09-30 | $1.50M 10-Q · filed 2019-10-28 | $2.94M derived: sum of 2 quarters · filed 2019-10-28 | $1.89M 10-Q · filed 2019-10-28 | $3.69M derived: sum of 4 quarters · filed 2020-03-06 | ||||
| 2018-06-30 | $1.44M 10-Q · filed 2019-07-26 | $394.00K 10-Q · filed 2019-07-26 | $2.19M derived: sum of 3 quarters · filed 2020-03-06 | $5.83M derived: sum of 4 quarters · filed 2020-03-06 | ||||
| 2018-03-31 | -$1.05M 10-Q · filed 2019-05-06 | $748.00K derived: sum of 2 quarters · filed 2020-03-06 | $4.39M derived: sum of 3 quarters · filed 2020-03-06 | $10.76M derived: sum of 4 quarters · filed 2020-03-06 | ||||
| 2017-12-31 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06 | $5.44M derived: sum of 2 quarters · filed 2020-03-06 | $11.81M derived: sum of 3 quarters · filed 2020-03-06 | $14.39M 10-K · filed 2020-03-06 | ||||
| 2017-09-30 | $3.64M 10-Q · filed 2018-10-26 | $10.02M derived: sum of 2 quarters · filed 2018-10-26 | $12.59M 10-Q · filed 2018-10-26 | $17.29M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-06-30 | $6.37M 10-Q · filed 2018-07-31 | $8.94M 10-Q · filed 2018-07-31 | $13.65M derived: sum of 3 quarters · filed 2019-02-27 | $18.48M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-03-31 | $2.57M 10-Q · filed 2018-05-10 | $7.28M derived: sum of 2 quarters · filed 2019-02-27 | $12.11M derived: sum of 3 quarters · filed 2019-02-27 | $17.01M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2016-12-31 | $4.70M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $9.53M derived: sum of 2 quarters · filed 2019-02-27 | $14.44M derived: sum of 3 quarters · filed 2019-02-27 | $18.32M 10-K · filed 2019-02-27 | ||||
| 2016-09-30 | $4.83M 10-Q · filed 2017-10-27 | $9.73M derived: sum of 2 quarters · filed 2017-10-27 | $13.62M 10-Q · filed 2017-10-27 | $19.68M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-06-30 | $4.90M 10-Q · filed 2017-07-28 | $8.79M 10-Q · filed 2017-07-28 | $14.85M derived: sum of 3 quarters · filed 2018-02-27 | $19.64M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-03-31 | $3.89M 10-Q · filed 2017-05-04 | $9.95M derived: sum of 2 quarters · filed 2018-02-27 | $14.74M derived: sum of 3 quarters · filed 2018-02-27 | $19.37M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2015-12-31 | $6.06M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $10.85M derived: sum of 2 quarters · filed 2018-02-27 | $15.48M derived: sum of 3 quarters · filed 2018-02-27 | $17.50M 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | $4.79M 10-Q · filed 2016-11-01 | $4.79M 10-Q · filed 2015-11-03 | $9.42M derived: sum of 2 quarters · filed 2016-11-01 | $11.44M 10-Q · filed 2016-11-01 | $11.43M 10-Q · filed 2015-11-03 | $15.75M derived: sum of 4 quarters · filed 2017-02-24 | ||
| 2015-06-30 | $4.63M 10-Q · filed 2016-08-01 | $4.63M 10-Q · filed 2015-08-04 | $6.65M 10-Q · filed 2016-08-01 | $6.65M 10-Q · filed 2015-08-04 | $10.96M derived: sum of 3 quarters · filed 2017-02-24 | $15.08M derived: sum of 4 quarters · filed 2017-02-24 | ||
| 2015-03-31 | $2.01M 10-Q · filed 2016-05-03 | $2.01M 10-Q · filed 2015-05-04 | $6.33M derived: sum of 2 quarters · filed 2017-02-24 | $10.45M derived: sum of 3 quarters · filed 2017-02-24 | $16.36M derived: sum of 4 quarters · filed 2017-02-24 | |||
| 2014-12-31 | $4.31M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $8.44M derived: sum of 2 quarters · filed 2017-02-24 | $14.35M derived: sum of 3 quarters · filed 2017-02-24 | $23.19M 10-K · filed 2017-02-24 | $23.19M 10-K · filed 2015-03-13 | |||
| 2014-09-30 | $4.13M 10-Q · filed 2015-11-03 | $10.03M derived: sum of 2 quarters · filed 2015-11-03 | $18.87M 10-Q · filed 2015-11-03 | $22.63M derived: sum of 4 quarters · filed 2016-03-10 | ||||
| 2014-06-30 | $5.91M 10-Q · filed 2015-08-04 | $14.75M 10-Q · filed 2015-08-04 | $18.50M derived: sum of 3 quarters · filed 2016-03-10 | $21.28M derived: sum of 4 quarters · filed 2016-03-10 | ||||
| 2014-03-31 | $8.84M 10-Q · filed 2015-05-04 | $12.60M derived: sum of 2 quarters · filed 2016-03-10 | $15.37M derived: sum of 3 quarters · filed 2016-03-10 | $18.84M derived: sum of 4 quarters · filed 2016-03-10 | ||||
| 2013-12-31 | $3.76M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $6.53M derived: sum of 2 quarters · filed 2016-03-10 | $10.00M derived: sum of 3 quarters · filed 2016-03-10 | $11.90M 10-K · filed 2016-03-10 | $11.91M 10-K · filed 2014-03-13 | |||
| 2013-09-30 | $2.78M 10-Q · filed 2014-11-06 | $6.24M derived: sum of 2 quarters · filed 2014-11-06 | $8.15M 10-Q · filed 2014-11-06 | $11.43M derived: sum of 4 quarters · filed 2015-03-13 | ||||
| 2013-06-30 | $3.47M 10-Q · filed 2014-08-04 | $5.37M 10-Q · filed 2014-08-04 | $8.66M derived: sum of 3 quarters · filed 2015-03-13 | $9.69M derived: sum of 4 quarters · filed 2015-03-13 | ||||
| 2013-03-31 | $1.90M 10-Q · filed 2014-05-05 | $5.19M derived: sum of 2 quarters · filed 2015-03-13 | $6.23M derived: sum of 3 quarters · filed 2015-03-13 | $8.57M derived: sum of 4 quarters · filed 2015-03-13 | ||||
| 2012-12-31 | $3.29M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $4.32M derived: sum of 2 quarters · filed 2015-03-13 | $6.67M derived: sum of 3 quarters · filed 2015-03-13 | $7.77M 10-K · filed 2015-03-13 | ||||
| 2012-09-30 | $1.04M 10-Q · filed 2013-11-05 | $3.38M derived: sum of 2 quarters · filed 2013-11-05 | $4.48M 10-Q · filed 2013-11-05 | $6.47M derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2012-06-30 | $2.35M 10-Q · filed 2013-08-06 | $3.45M 10-Q · filed 2013-08-06 | $5.43M derived: sum of 3 quarters · filed 2014-03-13 | $7.22M derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2012-03-31 | $1.10M 10-Q · filed 2013-05-06 | $3.08M derived: sum of 2 quarters · filed 2014-03-13 | $4.88M derived: sum of 3 quarters · filed 2014-03-13 | $6.23M derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2011-12-31 | $1.98M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | $3.78M derived: sum of 2 quarters · filed 2014-03-13 | $5.13M derived: sum of 3 quarters · filed 2014-03-13 | $5.32M 10-K · filed 2014-03-13 | ||||
| 2011-09-30 | $1.79M 10-Q · filed 2012-11-08 | $3.14M derived: sum of 2 quarters · filed 2012-11-08 | $3.34M 10-Q · filed 2012-11-08 | $4.42M derived: sum of 4 quarters · filed 2013-03-14 | ||||
| 2011-06-30 | $1.35M 10-Q · filed 2012-08-07 | $1.54M 10-Q · filed 2012-08-07 | $2.62M derived: sum of 3 quarters · filed 2013-03-14 | $3.48M derived: sum of 4 quarters · filed 2013-03-14 | ||||
| 2011-03-31 | $191.35K 10-Q · filed 2012-05-07 | $1.27M derived: sum of 2 quarters · filed 2013-03-14 | $2.13M derived: sum of 3 quarters · filed 2013-03-14 | $2.80M derived: sum of 4 quarters · filed 2013-03-14 | ||||
| 2010-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | $1.94M derived: sum of 2 quarters · filed 2013-03-14 | $2.61M derived: sum of 3 quarters · filed 2013-03-14 | $3.03M 10-K · filed 2013-03-14 | ||||
| 2010-09-30 | $853.49K 10-Q · filed 2011-11-04 | $1.53M derived: sum of 2 quarters · filed 2011-11-04 | $1.95M 10-Q · filed 2011-11-04 | |||||
| 2010-06-30 | $678.01K 10-Q/A · filed 2011-08-10 | $1.09M 10-Q/A · filed 2011-08-10 | ||||||
| 2009-12-31 | $1.82M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |